Market AnalysisIambic Raises $150M in an AI Drug Discovery IPO
TL;DR: Iambic Therapeutics, a San Diego AI drug discovery company, raised $150 million in its IPO, per BioPharma Dive , selling about 9.4 million shares at $16 each. It trades on Nasdaq as IAM from O…
Jeff Barnes, MBA··6 min read